So after watching this for a few years I have finally bought in. I'm no expert when it comes to biotech but last year I felt the risk of FDA rejection was too
high for me.
I made money once from a US biotech called Sarepta and learned then how long and tortuous the pathway to approval and then commercialisation can be. I have a feeling that MSB is now on a track that justifies the still high risk of investing. It is a binary play: it will either be zero or $10+, depending on your timeline (see next point).
My timeline for approval and commercialisation is 12 - 36 months. 12 being the best case, longer than 36 and I'll sell out and take the loss.
I note that this forum has some deep experts, far more knowledgeable than me, on the dark ways of the FDA approvals process. Anyone want to challenge my timeline?
- Forums
- ASX - By Stock
- MSB
- Share Cafe Webinar - Potency assay data was in place for GvHD trial
Share Cafe Webinar - Potency assay data was in place for GvHD trial, page-15
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.03 |
Change
-0.030(2.84%) |
Mkt cap ! $1.187B |
Open | High | Low | Value | Volume |
$1.06 | $1.06 | $1.02 | $1.511M | 1.455M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 31751 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 9290 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 79706 | 1.015 |
9 | 37597 | 1.010 |
7 | 40404 | 1.005 |
6 | 176769 | 1.000 |
5 | 288315 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 22153 | 11 |
1.030 | 31755 | 13 |
1.035 | 33953 | 7 |
1.040 | 23047 | 3 |
1.045 | 41900 | 7 |
Last trade - 15.40pm 25/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online